Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | PDK1 | Q15118 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1360905 | 0.97 | SMN1; SMN2 (0.54) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL3446854 | 0.95 | TSHR (0.55) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL1920460 | 0.95 | SMN1; SMN2 (0.53) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL7542607 | 0.93 | SMN1; SMN2 (0.50) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL6063082 | 0.92 | TSHR (0.55) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL8605595 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL20478200 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL16430091 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL44112 | 0.92 | SMN1; SMN2 (0.59) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 | |
| SCHEMBL6064488 | 0.91 | SMN1; SMN2 (0.53) | SMN1; SMN2TSHRALDH1A1TDP1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112724404-B | Hyperbranched phosphorus-nitrogen POSS-EP flame retardant, and preparation and application thereof | 东华大学 | 2023-10-10 | — | — | CN | claimed |
| CN-112724404-A | Hyperbranched phosphorus-nitrogen POSS-EP flame retardant, and preparation and application thereof | 东华大学 | 2021-04-30 | — | — | CN | claimed |
| EP-2678282-B1 | PROCESS FOR PREPARING HYBRID SOL-GEL COATED GLASS CONTAINERS | OWENS BROCKWAY GLASS CONTAINER (US) | 2020-08-05 | — | — | EP | claimed |
| WO-2012166221-A1 | HYBRID SOL-GEL COATED GLASS CONTAINERS | OWENS-BROCKWAY GLASS CONTAINER INC. (US) | 2012-12-06 | — | — | WO | claimed |
| US-20120217181-A1 | Hybrid Sol-Gel Coated Glass Containers | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT | 2012-08-30 | — | — | US | claimed |
| US-20250256011-A1 | HYDROGELS FOR SOFT TISSUE FILLING | Teoxane SA (CH) | 2025-08-14 | — | — | US | disclosed |
| US-20250255799-A1 | METHOD FOR PRODUCING HYDROGEL | Teoxane SA (CH) | 2025-08-14 | — | — | US | disclosed |
| US-20250249150-A1 | HYDROGELS FOR FILLING SOFT TISSUES | Teoxane SA (CH) | 2025-08-07 | — | — | US | disclosed |
| CN-119585354-A | Hydrogels for filling soft tissue | 泰奥赛恩股份公司 | 2025-03-07 | — | — | CN | disclosed |
| CN-119562987-A | Hydrogels for soft tissue filling | 泰奥赛恩股份公司 | 2025-03-04 | — | — | CN | disclosed |
| EP-4507653-A1 | METHOD FOR PRODUCING A HYDROGEL COMPRISING A CROSS-LINKED SILYLATED POLYSACCHARIDE | Teoxane SA (CH) | 2025-02-19 | — | — | EP | disclosed |
| EP-4508132-A1 | HYDROGELS FOR FILLING SOFT TISSUES | Teoxane SA (CH) | 2025-02-19 | — | — | EP | disclosed |
| CN-1231031-A | Plastic lenses and primer composition used for coating the same | NIPPON ARC CO LTD (JP) | 1999-10-06 | — | — | CN | disclosed |
| US-5963373-A | EPOXY, POLYISOCYANATE | NIPPON ARC CO., LTD. (JP) | 1999-10-05 | — | — | US | disclosed |
| EP-0922971-A1 | PLASTIC LENSES AND PRIMER COMPOSITION USED FOR COATING THE SAME | NIPPON ARC CO., LTD. (JP) | 1999-06-16 | — | — | EP | disclosed |
| US-5858077-A | Coating composition capable of yielding a cured product having a high refractive index and coated articles obtained therefrom | NIPPON ARC CO., LTD. (JP) | 1999-01-12 | — | — | US | disclosed |
| WO-1998058969-A1 | USE OF NANO-SCALED METAL OXIDE PARTICLES AS POLYMERISATION CATALYSTS | INSTITUT FÜR NEUE MATERIALIEN GEM. GMBH (DE) | 1998-12-30 | — | — | WO | disclosed |
| EP-0791636-A1 | PRIMER COMPOSITION | NIPPON ARC CO., LTD. (JP) | 1997-08-27 | — | — | EP | disclosed |
| US-5654090-A | A HARD CURIED FILM ON PLASTIC LENS COMPRISING INORGANIC OXIDE PARTICLES AND ADDITION POLYMER BINDER ANCHORING BY A EPOXY SILICON COMPOUND, CURING AGENTS; DYEABLE, WEATHERPROOFING | NIPPON ARC CO., LTD. (JP) | 1997-08-05 | — | — | US | disclosed |
| US-4975328-A | Adding a phosphoric acid release agent to the monomer mixture used in casting a polythiourethane | HOYA CORPORATION (JP) | 1990-12-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250255799-A1 | METHOD FOR PRODUCING HYDROGEL | CD44, MMP1, HPSE | SMN1; SMN2 4550/4885TSHR 2564/4885ALDH1A1 2403/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.